Evidence map›Paper›PMID 23325106›Full record

ArticleJAMA psychiatry2013

Implication of a rare deletion at distal 16p11.2 in schizophrenia.

Saurav Guha, Elliott Rees, Ariel Darvasi, Dobril Ivanov, Masashi Ikeda, Sarah E Bergen, Patrik K Magnusson, Paul Cormican, Derek Morris, Michael Gill and 38 more

Open access · greenAbstract read
In one paragraph

Article in JAMA psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Dissecting Schizophrenia Biology Using Pleiotropy with Cognitive Genomics.medRxiv : the preprint server for health sciences · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The genetics of bipolar disorder.Molecular psychiatry · 2020
    Review
  16. Article
  17. Nordic OCD & Related Disorders Consortium: Rationale, design, and methods.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2020
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors at 1 institution in 1 country.

Saurav GuhaDivision of Psychiatry Research, The Zucker Hillside Hospital, Glen Oaks, New York 11004, USA.
Elliott Rees
Ariel Darvasi
Dobril Ivanov
Masashi Ikeda
Sarah E Bergen
Patrik K Magnusson
Paul Cormican
Derek Morris
Michael Gill
Sven Cichon
Jeffrey A Rosenfeld
Annette Lee
Peter K Gregersen
John M Kane
Anil K Malhotra
Marcella Rietschel
Markus M Nöthen
Franziska Degenhardt
Lutz Priebe
René Breuer
Jana Strohmaier
Douglas M Ruderfer
Jennifer L Moran
Kimberly D Chambert
Alan R Sanders
Jianxin Shi
Kenneth Kendler
Brien Riley
Tony O'Neill
Dermot Walsh
Dheeraj Malhotra
Aiden Corvin
Shaun Purcell
Pamela Sklar
Nakao Iwata
Christina M Hultman
Patrick F Sullivan
Jonathan Sebat
Shane McCarthy
Pablo V Gejman
Douglas F Levinson
Michael J Owen
Michael C O'Donovan
Todd Lencz
George Kirov
Molecular Genetics of Schizophrenia Consortium
Wellcome Trust Case Control Consortium 2
Zucker Hillside Hospital · US

Funding

White Matter Abnormalities in SchizophreniaP50MH066392 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BUXBAUM, JOSEPH D. · 2002 to 2012
$18.6M
AN NCRR CENTER FOR HIGH THROUGHPUT SNP GENOTYPING AND ANALYSIS: GAIN NETWORKU54RR020278 · NCRR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY · 2004 to 2008
$14.4M
Striatal D2/D3 Dopamine receptor availability in first episode schizophreniaP50MH080173 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI GREGERSEN, PETER K. · 2008 to 2012
$10.4M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059571 · NIMH · UNIVERSITY OF CHICAGO · PI GEJMAN, PABLO V. · 1999 to 2007
$8.0M
Trials Operation Unit (OPERATIONS CORE)P30MH090590 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORRELL, CHRISTOPH U · 2010 to 2014
$7.9M
A Genome-Wide Association Study of SchizophreniaU01MH079469 · NIMH · NORTHSHORE UNIVERSITY HEALTHSYSTEM · PI GEJMAN, PABLO V. · 2007 to 2009
$4.4M
2/2 Large-Scale Genetic Studies of Schizophrenia in SwedenR01MH095034 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI STAHL, ELI A · 2012 to 2019
$3.6M
A genome-wide association study of schizophrenia in IrelandR01MH083094 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI RILEY, BRIEN P · 2008 to 2011
$3.5M
Common and Rare Genetic Factors in an Ethnically Homogeneous Schizophrenia CohortRC2MH089964 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI LENCZ, TODD · 2009 to 2010
$3.5M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH060879 · NIMH · WASHINGTON UNIVERSITY · PI CLONINGER, C. ROBERT · 1999 to 2006
$2.7M
3/4-Psychiatric GWAS Consortium: Genomic Follow-Up Next-Gen Sequencing & GenotypiU01MH094411 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SEBAT, JONATHAN · 2012 to 2015
$2.7M
MOLECULAR GENETICS OF SCHIZOPHRENIAR01MH059586 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SILVERMAN, JEREMY M. · 1999 to 2006
$1.9M
Medical Research Council G0000934Medical Research Council G0800509NCRR NIH HHS U54 RR020278NIMH NIH HHS 2 P50 MH066392-05A1NIMH NIH HHS MH46276NIMH NIH HHS MH46289NIMH NIH HHS MH46318NIMH NIH HHS MH59565NIMH NIH HHS MH59566NIMH NIH HHS MH59571NIMH NIH HHS MH59586NIMH NIH HHS MH59587NIMH NIH HHS MH59588NIMH NIH HHS MH60870NIMH NIH HHS MH60879NIMH NIH HHS MH61675NIMH NIH HHS MH67257NIMH NIH HHS MH79469NIMH NIH HHS MH79470NIMH NIH HHS MH81800NIMH NIH HHS P30 MH090590NIMH NIH HHS P50 MH066392NIMH NIH HHS P50 MH080173NIMH NIH HHS R01 MH059565NIMH NIH HHS R01 MH059566NIMH NIH HHS R01 MH059571NIMH NIH HHS R01 MH059586NIMH NIH HHS R01 MH059587NIMH NIH HHS R01 MH059588NIMH NIH HHS R01 MH060870NIMH NIH HHS R01 MH060879NIMH NIH HHS R01 MH061675NIMH NIH HHS R01 MH067257NIMH NIH HHS R01 MH081800NIMH NIH HHS R01 MH083094NIMH NIH HHS R01 MH084098NIMH NIH HHS R01 MH095034NIMH NIH HHS RC2 MH089964NIMH NIH HHS U01 MH046276NIMH NIH HHS U01 MH046289NIMH NIH HHS U01 MH046318NIMH NIH HHS U01 MH079469NIMH NIH HHS U01 MH079470NIMH NIH HHS U01 MH094411Wellcome TrustWellcome Trust 068545/Z/02Wellcome Trust 085475/B/08/ZWellcome Trust 085475/Z/08/Z
6 · The paper itself

Abstract

contextLarge genomic copy number variations have been implicated as strong risk factors for schizophrenia. However, the rarity of these events has created challenges for the identification of further pathogenic loci, and extremely large samples are required to provide convincing replication.

objectiveTo detect novel copy number variations that increase the susceptibility to schizophrenia by using 2 ethnically homogeneous discovery cohorts and replication in large samples.

designGenetic association study of microarray data.

settingSamples of DNA were collected at 9 sites from different countries.

participantsTwo discovery cohorts consisted of 790 cases with schizophrenia and schizoaffective disorder and 1347 controls of Ashkenazi Jewish descent and 662 parent-offspring trios from Bulgaria, of which the offspring had schizophrenia or schizoaffective disorder. Replication data sets consisted of 12,398 cases and 17,945 controls.

main outcome measuresStatistically increased rate of specific copy number variations in cases vs controls.

resultsOne novel locus was implicated: a deletion at distal 16p11.2, which does not overlap the proximal 16p11.2 locus previously reported in schizophrenia and autism. Deletions at this locus were found in 13 of 13,850 cases (0.094%) and 3 of 19,954 controls (0.015%) (odds ratio, 6.25 [95% CI, 1.78-21.93]; P = .001, Fisher exact test).

conclusionsDeletions at distal 16p11.2 have been previously implicated in developmental delay and obesity. The region contains 9 genes, several of which are implicated in neurological diseases, regulation of body weight, and glucose homeostasis. A telomeric extension of the deletion, observed in about half the cases but no controls, potentially implicates an additional 8 genes. Our findings add a new locus to the list of copy number variations that increase the risk for development of schizophrenia.

Indexed as

Base SequenceSequence DeletionCase-Control StudiesChromosomes, Human, Pair 16Cohort StudiesDNA Copy Number VariationsFemaleGenetic Predisposition to DiseaseGenotypeHumansMalePsychotic DisordersRisk FactorsSchizophrenia

Identifiers

PMID23325106
PMCPMC3750982
OpenAlexW2116611710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.